Edin Sadic

Edin Sadic

Auto-generated profile, based on publicly available information

Edin Sadic

Cardiology, University of Florida College of Medicine, Jacksonville, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 July 2021 in Case Reports in Cardiology
Verified
Journal Article
Open access
PDF file
NMNaji Maaliki
Naji Maaliki
MOMichael Omar
Michael Omar
AAAleem Azal Ali
Aleem Azal Ali
ARAmy Roemer
Amy Roemer
JRJose Ruiz
Jose Ruiz
ESEdin Sadic
Edin Sadic
A 50-year-old male presented for loss of consciousness. He was initially treated with intravenous epinephrine and fluids, and an electrocardiogram (ECG) displayed an ST-segment elevation in lead aVR with global ST-segment depressions. A subsequent left heart catheterization revealed that the middle segment of the left anterior descending artery (LAD) demonstrated severe stenosis during systole but would become patent during diastole, which was suggestive of myocardial bridging. After stopping the epinephrine and increasing the fluid infusion, the ECG changes rapidly resolved. The patient had later admitted to significant dehydration all day. Myocardial bridging is a congenital anomaly in which a coronary artery segment courses through the myocardium instead of the usual epicardial surface. Occasionally, myocardial bridging may present similarly to acute coronary syndrome in severe dehydration or hyperadrenergic states. The diagnosis can be made through coronary angiography, which reveals a dynamic vessel obstruction pattern corresponding with the cardiac cycle. Long-term effects may also include accelerated atherosclerosis. Treatment consists of reversing precipitating causes during acute presentations and decreasing the risk of coronary artery disease on a chronic basis.

1 June 2020 in CASE
Verified
Journal Article
Open access
ESEdin Sadic
Edin Sadic
KEKhadeeja Esmail
Khadeeja Esmail
RPRobert Percy
Robert Percy
EMEmil Missov
Emil Missov
SSSrinivasan Sattiraju
Srinivasan Sattiraju

1 January 2026 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
ESEdin Sadic
Edin Sadic
SSSahab Sadic
Sahab Sadic
Drug‐coated balloons (DCBs) have emerged as an established treatment strategy for in‐stent restenosis (ISR) and selected de novo coronary lesions, particularly in small vessels. Unlike stents, DCBs deliver antiproliferative therapy without leaving a permanent intracoronary implant, thereby avoiding chronic inflammation, neoatherosclerosis, and late stent‐related complications. While the efficacy and safety of DCBs in ISR are well supported, data regarding their use in the setting of acute coronary syndrome (ACS) remain limited, where plaque rupture, thrombus burden, and heightened thrombotic risk raise unique procedural concerns. This review summarizes the available evidence evaluating the safety and efficacy of DCBs in ACS, including randomized controlled trials, observational studies, and registry data published over the past decade. We review outcomes across ACS subtypes, including ST‐segment elevation myocardial infarction (STEMI) and non‐ST‐segment elevation myocardial infarction (NSTEMI), and discuss lesion preparation strategies, thrombus management, bifurcation disease, and differences among drug‐coating technologies. Current evidence suggests that, in carefully selected patients with adequate lesion preparation and acceptable angiographic results, a DCB‐based strategy may offer outcomes comparable to contemporary drug‐eluting stents, while potentially reducing late device‐related complications and duration of dual antiplatelet therapy. Further prospective studies are needed to define optimal patient selection and procedural techniques, particularly in lesions with high thrombus burden.

1 April 2021 in CASE
Verified
Journal Article
Open access
ESEdin Sadic
Edin Sadic
JMJose Ruiz Morales
Jose Ruiz Morales
EMEmil Missov
Emil Missov
RPRobert Percy
Robert Percy
SSSrinivasan Sattiraju
Srinivasan Sattiraju
• Cardiac complications are the most common cause of death in dialysis patients. • Cardiac complications include coronary disease, arrhythmias, and valvular disease. • Valvular calcification can lead to valve dysfunction, conduction issues, and embolism. • With an increasingly dialysis-dependent and aged population, clinical prevalence is high.